After opening mildly in the red, Dalal Street fell prey to significant selling pressure through the Friday, July 11 session, as investors rushed to book profits amid concerns of a lacklustre earnings season, following IT giant Tata Consultancy Services' weak quarterly show and disappointing commentary.
Glenmark Pharmaceuticals | CMP Rs 2,181 | Shares surged an intraday high of 17 percent after the company announced that its subsidiary has signed an exclusive global licensing agreement for its investigational asset ISB 2001 with New York-based AbbVie. ISB 2001 is currently in the first phase of clinical trials for patients suffering from relapsed or refractory multiple myeloma, a type of cancer, the company said in an exchange filing.
Hindustan Unilever | CMP Rs 2,519 | Stock jumped up to 5 percent on July 11 after the company announced Priya Nair as its new MD & CEO, succeeding Rohit Jawa, who steps down after a two-year stint. Nair, currently President of Beauty & Wellbeing, will be the first woman to lead HUL in its 92-year history. She oversees a €13.2 billion global portfolio, including brands like Dove, Sunsilk, Clear, and Vaseline.
TCS | CMP Rs 3,266 | Shares tanked 3.5 following its Q1 earnings which deepened concerns around the broader Q1 earnings season, with experts flagging limited clarity on growth prospects for FY26 for the IT major. Brokerages noted that the company’s constant currency growth missed street expectations, and cautioned that a meaningful margin improvement over the rest of the year appears unlikely.
IREDA | CMP Rs 160 |Indian Renewable Energy Development Agency (IREDA) slipped 6 percent after its asset quality took a sharp hit in the June quarter, overshadowing strong loan growth and denting investor sentiment. The state-run lender reported a 35.7 percent year-on-year drop in net profit to Rs 247 crore, largely due to a rise in bad loans.
Tata Elxsi | CMP Rs 6,066 | The stock tanked as much as 4 percent after the company reported a sharp drop in June quarter earnings, triggering concerns over demand headwinds and margin pressure. The disappointing performance also prompted global brokerages to cut estimates and maintain bearish views on the stock.
Zee Entertainment |CMP Rs 137 | The stock price plunged over 3 percent on July 11 after promoters received a second setback from shareholders, as investors voted against the proposed capital infusion of Rs 2,237 crore through preferential warrants.
Dreamfolks Services | CMP Rs 160 |Shares hit a new low of Rs 158, falling over 3 percent on July 11 following the closure of the programmes run for its clients, including Axis Bank, and ICICI Bank, effective from July 1, 2025. In terms of technicals, the relative strength index (RSI) of Dreamfolks Services stands at 19.7, signaling it's trading in the oversold territory.
Mankind Pharma | CMP Rs 2,578 | Shares of Mankind Pharma gained as much as 6 percent on July 11, before paring almost all gains, after brokerage firm Jefferies increased its price target on the healthcare firm, projecting a potential upside to 18 percent from its previous closing price.
RPP Infra | CMP Rs 141 | RPP Infra shares rose as much as 5 percent on July 11 after the company announced that it had secured orders worth Rs 365.85 crore in Rajasthan. The company said the order was awarded to RPP-BCC IV, a joint venture in which RPP Infra holds a 51 percent stake.
Bharti Airtel | CMP Rs 1,922 | Shares slipped over 2 percent after UBS downgraded the stock amid expensive valuations. The brokerage is expecting a 10 percent ARPU hike over FY25-28, with later years largely being driven by secular factors. Even the FY26 tariff hike faces the risk of being delayed or coming in with a lower magnitude than anticipated.
